Genesis Biosciences

Genesis Biosciences is a private, revenue-generating company operating in the industrial and environmental microbiome sector. It utilizes a core platform of bacterial fermentation and eco-benign® technology to produce a diverse portfolio of microbial-based products sold under brands like Evogen, Evozyme, and Evobac. With manufacturing and R&D facilities in the US and Europe, the company serves a global customer base across multiple verticals, including industrial cleaning, wastewater management, agriculture, and aquaculture, emphasizing performance, sustainability, and rigorous quality control.

Proprietary bacterial strain fermentation and formulation platform centered on 'eco-benign®' technology for developing microbial and antimicrobial products.

Operates in the competitive industrial and environmental microbiome sector, competing with other specialty biotech firms (e.g., Novozymes, Lallemand's specialty divisions) and green chemistry companies. Differentiation is based on proprietary strain libraries, fermentation expertise, and the eco-benign® formulation platform. Large chemical companies may also be potential competitors or future partners.